CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Eyenovia, Inc. - EYEN CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 1.50-3.34
平均交易量(10 天) 103.72K
平均交易量(3 个月) 4.11M
市值 107.64M
市盈率 -100.00K
流通股 36.12M
收入 10.00M
EPS -0.56
股息(收益率 %) N/A
贝塔 1.67
下一个财报发布日期 Mar 30, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Eyenovia, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 14 2 0 0 0
收入 14 2 0
总营业费用 26.4403 21.7892 21.3085 17.2564 5.13237
销售/一般/行政费用,总计 10.7842 7.69759 7.20051 6.13618 1.31564
研究与开发 14.2979 13.1962 14.0927 11.1011 3.79127
Depreciation / Amortization 0.22156 0.09542 0.01534 0.01913 0.02547
营业收入 -12.4403 -19.7892 -21.3085 -17.2564 -5.13237
利息收入(费用),非经营净值 -0.38524 0.00936 0.15179 0.00334 0.00238
税前净收入 -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
税后净收入 -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
未计算非常项目前的净收益 -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
净收入 -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
普通股股东可获收益 (不含非经常性项目) -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
普通股股东可获收益 (含非經常性項目) -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
摊薄调整
摊薄净收入 -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
摊薄后加权平均股 26.3241 21.0547 14.3497 9.47671 9.93677
扣除特别项目的每股摊薄盈利 -0.48543 -0.93898 -1.47437 -1.82058 -0.51626
Dividends per Share - Common Stock Primary Issue
每股正常摊薄盈利 -0.50303 -0.93898 -1.47437 -1.82058 -0.51626
非常规项目总计 0
收入成本,共计 1.6 0.8
毛利 12.4 1.2
其他,净值 0.04718 0.01
异常费用(收入) -0.46335
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
总收入 0 0 0 10 0
收入 0 0 0 10 0
收入成本,共计 0 0 0 0 0
毛利 0 0 0 10 0
总营业费用 7.23023 7.12146 7.18755 6.88673 5.46171
销售/一般/行政费用,总计 3.35335 3.53459 3.47497 3.7115 2.373
研究与开发 3.87688 3.58687 3.71258 3.17523 3.55207
营业收入 -7.23023 -7.12146 -7.18755 3.11327 -5.46171
利息收入(费用),非经营净值 -0.14905 -0.15102 -0.14505 -0.18519 -0.11861
其他,净值 0.07028 0.03338 -0.00707 0.05519 0.01173
税前净收入 -7.309 -7.2391 -7.33967 2.98328 -5.5686
税后净收入 -7.309 -7.2391 -7.33967 2.98328 -5.5686
未计算非常项目前的净收益 -7.309 -7.2391 -7.33967 2.98328 -5.5686
净收入 -7.309 -7.2391 -7.33967 2.98328 -5.5686
普通股股东可获收益 (不含非经常性项目) -7.309 -7.2391 -7.33967 2.98328 -5.5686
普通股股东可获收益 (含非經常性項目) -7.309 -7.2391 -7.33967 2.98328 -5.5686
摊薄净收入 -7.309 -7.2391 -7.33967 2.98328 -5.5686
摊薄后加权平均股 34.6318 33.6449 30.0082 27.977 26.0535
扣除特别项目的每股摊薄盈利 -0.21105 -0.21516 -0.24459 0.10663 -0.21374
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.21105 -0.21516 -0.24459 0.10663 -0.23152
异常费用(收入) 0 0 -0.46335
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 29.8769 33.3913 14.3493 19.861 5.28666
现金和短期投资 19.4618 28.3718 14.1526 19.7282 5.24951
Cash 19.4618 28.3718 14.1526 19.7282 5.24951
Prepaid Expenses 0.38663 0.2898 0.07737 0.13276 0.03715
Total Assets 31.6591 33.9068 14.6976 20.0155 5.64332
Property/Plant/Equipment, Total - Net 1.27123 0.39638 0.23054 0.03674 0.02796
Property/Plant/Equipment, Total - Gross 1.59963 0.57329 0.31203 0.10289 0.07498
Accumulated Depreciation, Total -0.32841 -0.17691 -0.08149 -0.06615 -0.04702
Total Current Liabilities 11.1725 18.1984 2.91166 3.09884 0.55265
Accounts Payable 1.6141 1.46167 1.54136 1.50952 0.24638
Accrued Expenses 2.32693 2.57974 1.31332 1.56769 0.29529
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.08109 14.0594 0.05698 0.02163 0.01098
Total Liabilities 11.1924 18.6029 2.95701 3.14043 0.55265
Total Long Term Debt 0 0.36581 0 0 0
Other Liabilities, Total 0.01995 0.03868 0.04535 0.04158 0
Total Equity 20.4666 15.3039 11.7406 16.8751 5.09067
Redeemable Preferred Stock 0 0 0
Preferred Stock - Non Redeemable, Net 0.00046
Common Stock 0.00284 0.0025 0.00171 0.00115 0.00026
Additional Paid-In Capital 110.683 92.7423 69.41 53.3882 24.3511
Retained Earnings (Accumulated Deficit) -90.2193 -77.4409 -57.6711 -36.5143 -19.2612
Total Liabilities & Shareholders’ Equity 31.6591 33.9068 14.6976 20.0155 5.64332
Total Common Shares Outstanding 28.4266 24.9786 17.1007 11.469 9.93677
Other Long Term Assets, Total 0.51098 0.11904 0.1178 0.1178 0.3287
应收账款总额,净额 2.14885 3.11798 0.09523
Other Current Assets, Total 7.87953 1.61173 0.02408
Current Port. of LT Debt/Capital Leases 7.15037 0.09754
Long Term Debt 0 0.36581
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 30.3986 29.8769 23.4593 29.495 28.0252
现金和短期投资 26.7163 19.4618 13.5009 27.1768 24.907
Cash 26.7163 19.4618 13.5009 27.1768 24.907
应收账款总额,净额 1.85222 2.14885 1.25767 1.17134 1.17891
Prepaid Expenses 1.79656 0.38663 0.77768 1.04895 1.089
Other Current Assets, Total 0.03358 7.87953 7.92312 0.09787 0.85025
Total Assets 40.1881 31.6591 24.9916 30.5829 28.8517
Property/Plant/Equipment, Total - Net 1.37036 1.27123 1.4132 0.96888 0.70742
Other Long Term Assets, Total 8.41907 0.51098 0.11904 0.11904 0.11904
Total Current Liabilities 10.3788 11.1725 20.7194 14.5598 16.3656
Accounts Payable 1.53476 1.6141 1.68473 1.66763 1.81512
Accrued Expenses 1.05726 2.32693 1.68645 1.86687 1.7253
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.74012 7.15037 7.28204 0.95976 0.78382
Other Current Liabilities, Total 0.04662 0.08109 10.0662 10.0656 12.0414
Total Liabilities 10.3939 11.1924 20.7454 21.5924 16.7115
Total Long Term Debt 0 0 0 6.99489 0.30729
Long Term Debt 0 0 6.99489 0.30729
Other Liabilities, Total 0.01508 0.01995 0.02606 0.03763 0.03863
Total Equity 29.7942 20.4666 4.24614 8.99056 12.1401
Redeemable Preferred Stock 0 0 0
Common Stock 0.00317 0.00284 0.0026 0.0026 0.00256
Additional Paid-In Capital 127.35 110.683 97.4461 96.6219 94.9301
Retained Earnings (Accumulated Deficit) -97.559 -90.2193 -93.2026 -87.634 -82.7926
Total Liabilities & Shareholders’ Equity 40.1881 31.6591 24.9916 30.5829 28.8517
Total Common Shares Outstanding 31.6984 28.4266 25.9632 25.9466 25.6236
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -12.7784 -19.7699 -21.1568 -17.2531 -5.12999
经营活动产生的现金 -20.8744 -6.38428 -18.9193 -13.1111 -4.73111
经营活动产生的现金 0.22156 0.09542 0.01534 0.01913 0.02547
非现金物品 2.43593 2.48317 2.51194 1.61547 0.41231
Cash Taxes Paid
已付现金利息 0.22717 0.01397
营运资金的变化 -10.7535 10.807 -0.28984 2.50737 -0.0389
投资活动产生的现金 -1.61852 -0.26126 -0.16664 -0.02791 -0.01023
资本支出 -1.22658 -0.26126 -0.16664 -0.02791 -0.01023
其他投资现金流量项目,总计 -0.39194
融资活动产生的现金 21.458 20.8648 13.5104 27.6177 6.60357
股票的发行(报废),净额 14.7299 20.8766 13.5104 27.6177 6.60357
现金净变化 -1.03498 14.2192 -5.5756 14.4787 1.86222
债务的发行(退还),净额 6.72802 -0.01186
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -7.33967 -12.7784 -15.7617 -10.1931 -5.35167
Cash From Operating Activities -8.1844 -20.8744 -14.9978 -9.90314 -4.57385
Cash From Operating Activities 0.07543 0.22156 0.14825 0.07524 0.03328
Non-Cash Items 0.9352 2.43593 1.65033 1.30978 0.65691
Cash Interest Paid 0.09559 0.22717 0.13184 0.07046 0.004
Changes in Working Capital -1.85537 -10.7535 -1.03471 -1.0951 0.08763
Cash From Investing Activities -0.20766 -1.61852 -1.16507 -0.64774 -0.34432
Capital Expenditures -0.17457 -1.22658 -1.16507 -0.64774 -0.34432
Cash From Financing Activities 15.6465 21.458 9.16692 9.3559 1.45339
Financing Cash Flow Items -0.08339 0
Issuance (Retirement) of Stock, Net 15.8417 14.7299 2.28079 2.23408 1.53099
Issuance (Retirement) of Debt, Net -0.11179 6.72802 6.88612 7.12182 -0.0776
Net Change in Cash 7.25442 -1.03498 -6.99596 -1.19499 -3.46478
Cash Taxes Paid 0 0
Other Investing Cash Flow Items, Total -0.0331 -0.39194
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Grant (Stuart M) Individual Investor 14.2096 5132677 21753 2022-12-30 LOW
Eshelman (Fredric N) Individual Investor 4.4624 1611872 -6963 2022-11-10 LOW
Ianchulev (Tsontcho M.D.) Individual Investor 3.3016 1192562 -21316 2022-12-27 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.5451 919322 -8433 2022-12-31 LOW
Medical Strategy GmbH Investment Advisor 1.922 694259 0 2022-09-30 LOW
Avenue Capital Group Investment Advisor/Hedge Fund 1.5166 547807 547807 2022-12-31 HIGH
Mario (Ernest B) Individual Investor 1.0595 382706 6963 2021-11-17 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.9314 336432 336432 2022-12-31 LOW
Palisade Capital Management, LLC Investment Advisor/Hedge Fund 0.8721 315029 315029 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.7987 288500 24400 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.72 260067 6056 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.2507 90568 14153 2022-12-31 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2035 73517 11900 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1954 70581 1159 2022-12-31 LOW
Mather (Charles E IV) Individual Investor 0.1953 70544 22222 2022-06-16 LOW
Clasby (Jennifer G) Individual Investor 0.1842 66537 10835 2021-06-17
Lee (Kenneth B Jr) Individual Investor 0.1787 64544 22222 2022-06-16 LOW
Bridgeway Capital Management, LLC Investment Advisor 0.1326 47900 0 2022-12-31 LOW
Oak Family Advisors, LLC Investment Advisor/Hedge Fund 0.1276 46073 -13113 2022-12-31 MED
BNY Mellon Asset Management Investment Advisor 0.1228 44374 -1136 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Eyenovia, Inc. Company profile

关于 Eyenovia Inc.

Eyenovia, Inc.是一家处于临床阶段的眼科公司。 该公司正在开发一条基于微剂量阵列打印(MAP)平台技术的治疗管道。 其管线主要集中在针对渐进性近视、老花眼和散瞳的微剂量药物的后期开发。 该公司的候选产品包括MydCombi、MicroPine和MicroLine。 MydCombi是一种用于药物性眼球扩张(眼球扩张)的组合微制剂产品(苯肾上腺素-托吡卡胺)。 MicroPine是一种治疗进行性近视的局部疗法,这是一种与病理性轴伸长和巩膜拉伸有关的眼底疾病。 微线是一种候选药物,它正在开发微剂量的皮罗卡平,这是一种眼科药物,可以按剂量诱导瞳孔收缩,即瞳孔收缩。

Industry: Pharmaceuticals (NEC)

295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,825.50 Price
+0.080% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

XRP/USD

0.47 Price
+4.900% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00483

Gold

1,951.94 Price
-1.450% 1D Chg, %
多头隔夜费 -0.0180%
空头隔夜费 0.0098%
隔夜费时间 21:00 (UTC)
价差 0.30

BTC/USD

28,006.45 Price
+0.450% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易